Identiv and Tag-N-Trac Collaborate to Enhance Pharmaceutical Supply Chain Visibility.
PorAinvest
jueves, 24 de abril de 2025, 7:57 pm ET1 min de lectura
COLD--
The partnership combines Identiv's BLE smart labels with Tag-N-Trac's RELATIVITY™ SaaS platform, enabling continuous monitoring of environmental conditions such as temperature and humidity. This integrated solution captures and analyzes data throughout the product's transit, ensuring compliance and integrity across the cold chain.
The collaboration addresses growing regulatory requirements and patient safety concerns, particularly for temperature-sensitive products like vaccines and biologics. The solution offers item-level visibility, providing real-time analytics for location, condition, and chain-of-custody verification. This granularity is a significant advancement over traditional shipment-level tracking, allowing pharmaceutical companies to verify the integrity of individual products rather than making assumptions based on container-level data.
From a market perspective, this partnership positions Identiv within a pharmaceutical segment driven by regulatory compliance requirements rather than optional technology adoption. As regulations around pharmaceutical distribution continue to evolve, solutions that provide documented evidence of proper handling become increasingly essential.
The platform's ability to monitor conditions in both "in warehouse" and "in transit" settings offers a unified approach to cold chain management, addressing potential blind spots in traditional systems. This continuous monitoring capability is crucial for maintaining the safety and efficacy of temperature-sensitive medications, where even brief deviations can render products ineffective or unsafe.
The partnership underscores the industry's increasing pressure to digitize supply chains for both safety and efficiency. Solutions that offer comprehensive documentation of proper handling will become standard practice rather than a competitive advantage, as regulatory requirements continue to evolve.
References:
[1] https://www.stocktitan.net/news/INVE/identiv-partners-with-tag-n-trac-to-market-io-t-solutions-for-cold-vr68km8qbwsb.html
INVE--
IOT--
Identiv and Tag-N-Trac have partnered to develop IoT solutions for cold chain monitoring in the pharmaceutical sector. The collaboration integrates Identiv's BLE smart labels with Tag-N-Trac's RELATIVITY SaaS platform, offering item-level visibility, real-time data, and traceability from warehouse to delivery. The platform monitors environmental conditions like temperature and humidity to maintain the safety and compliance of pharmaceutical products.
In a strategic move to enhance cold chain monitoring in the pharmaceutical sector, Identiv (NASDAQ: INVE) has announced a partnership with Tag-N-Trac. The collaboration aims to develop and market IoT solutions that provide real-time visibility and traceability for temperature-sensitive pharmaceutical products.The partnership combines Identiv's BLE smart labels with Tag-N-Trac's RELATIVITY™ SaaS platform, enabling continuous monitoring of environmental conditions such as temperature and humidity. This integrated solution captures and analyzes data throughout the product's transit, ensuring compliance and integrity across the cold chain.
The collaboration addresses growing regulatory requirements and patient safety concerns, particularly for temperature-sensitive products like vaccines and biologics. The solution offers item-level visibility, providing real-time analytics for location, condition, and chain-of-custody verification. This granularity is a significant advancement over traditional shipment-level tracking, allowing pharmaceutical companies to verify the integrity of individual products rather than making assumptions based on container-level data.
From a market perspective, this partnership positions Identiv within a pharmaceutical segment driven by regulatory compliance requirements rather than optional technology adoption. As regulations around pharmaceutical distribution continue to evolve, solutions that provide documented evidence of proper handling become increasingly essential.
The platform's ability to monitor conditions in both "in warehouse" and "in transit" settings offers a unified approach to cold chain management, addressing potential blind spots in traditional systems. This continuous monitoring capability is crucial for maintaining the safety and efficacy of temperature-sensitive medications, where even brief deviations can render products ineffective or unsafe.
The partnership underscores the industry's increasing pressure to digitize supply chains for both safety and efficiency. Solutions that offer comprehensive documentation of proper handling will become standard practice rather than a competitive advantage, as regulatory requirements continue to evolve.
References:
[1] https://www.stocktitan.net/news/INVE/identiv-partners-with-tag-n-trac-to-market-io-t-solutions-for-cold-vr68km8qbwsb.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios